Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Schuster

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Nursing Management|June 1, 1997
Wholistic care. Healing a "sick" systemS J Schuster
Vox Sanguinis|January 1, 1993
Erythropoietin: physiologic basis for clinical applicationsS J Schuster, J Caro
Clinical Lymphoma|November 15, 2001
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomographyA Matthies, S J Schuster, A Alavi
Hematologic Pathology|January 1, 1987
Erythropoietin: current concepts and future prospectsS J Schuster, J Caro, A J Erslev
Transfusion Medicine Reviews|October 1, 1989
Is there an optimal hemoglobin level?A J Erslev, J Caro, S J Schuster
European Journal of Haematology|November 1, 1989
Erythropoietin and its clinical promiseA J Erslev, S J Schuster, J Caro
American Journal of Hematology|September 2, 1998
Analysis of clonality using X-linked polymorphisms in a patient with multiple myeloma and myelofibrosisJ P Stevenson, R Schwarting, S J Schuster
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Clinical experience with lenalidomide alone or in combination with rituximab in indolent B-cell and mantle cell lymphomasJ Ruan, B Shah, P Martin, et al.
American Journal of Hematology|July 14, 1998
Waldenström's macroglobulinemia resulting from localized gastric lymphoplasmacytoid lymphomaJ A Rosenthal, W J Curran, S J Schuster
Seminars in Oncology|March 12, 1999
Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia?G Garcia-Manero, S J Schuster, M E Agha
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Nursing Management|June 1, 1997
Wholistic care. Healing a "sick" systemS J Schuster
Vox Sanguinis|January 1, 1993
Erythropoietin: physiologic basis for clinical applicationsS J Schuster, J Caro
Clinical Lymphoma|November 15, 2001
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomographyA Matthies, S J Schuster, A Alavi
Hematologic Pathology|January 1, 1987
Erythropoietin: current concepts and future prospectsS J Schuster, J Caro, A J Erslev
Transfusion Medicine Reviews|October 1, 1989
Is there an optimal hemoglobin level?A J Erslev, J Caro, S J Schuster
European Journal of Haematology|November 1, 1989
Erythropoietin and its clinical promiseA J Erslev, S J Schuster, J Caro
American Journal of Hematology|September 2, 1998
Analysis of clonality using X-linked polymorphisms in a patient with multiple myeloma and myelofibrosisJ P Stevenson, R Schwarting, S J Schuster
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Clinical experience with lenalidomide alone or in combination with rituximab in indolent B-cell and mantle cell lymphomasJ Ruan, B Shah, P Martin, et al.
American Journal of Hematology|July 14, 1998
Waldenström's macroglobulinemia resulting from localized gastric lymphoplasmacytoid lymphomaJ A Rosenthal, W J Curran, S J Schuster
Seminars in Oncology|March 12, 1999
Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia?G Garcia-Manero, S J Schuster, M E Agha
Pageof 5